Publications
Nirsevimab Effectiveness Against Intensive Care Unit Admission for Respiratory Syncytial Virus in Infants - 24 States, December 2024-April 2025
Morbidity and Mortality Weekly Report
November 20, 2025
Neurologic and Psychological Outcomes 2 Years After Multisystem Inflammatory Syndrome in ChildrenJAMA Network OpenJune 2, 2025
Concordance between parent-reported and documented COVID-19 vaccination status among hospitalized children and adolescents: Implications for vaccine effectiveness estimates, May 2021–October 2023VaccineApril 30, 2025
High expression of oleoyl-ACP hydrolase underpins life-threatening respiratory viral diseasesCellAugust 22, 2024
Molecular mimicry in multisystem inflammatory syndrome in childrenNatureAugust 7, 2024
Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron–Associated Hospitalization in Children and Adolescents — United States, 2021–2023Morbidity and Mortality Weekly ReportApril 18, 2024
Pre-existing Immunocompromising Conditions and Outcomes of Acute COVID-19 Patients Admitted for Pediatric Intensive CareClinical Infectious DiseasesMarch 11, 2024
Characteristics and Clinical Outcomes of Vaccine-Eligible US Children Under-5 Years Hospitalized for Acute COVID-19 in a National NetworkThe Pediatric Infectious Disease JournalMarch 2024
The Modified Clinical Progression Scale for Pediatric Patients: Evaluation as a Severity Metric and Outcome Measure in Severe Acute Viral Respiratory Illness
Pediatric Critical Care MedicineDecember 2023
Risk factors for health impairments in children after hospitalization for acute COVID-19 or MIS-C
Frontiers in PediatricsOctober 17, 2023
Effectiveness of Maternal mRNA COVID-19 Vaccination During Pregnancy Against COVID-19–Associated Hospitalizations in Infants Aged <6 Months During SARS-CoV-2 Omicron Predominance — 20 States, March 9, 2022–May 31, 2023
Morbidity and Mortality Weekly Report
September 29, 2023
Neurological and Psychological Sequelae Associated With Multisystem Inflammatory Syndrome in Children
JAMA Network Open
July 3, 2023
Risk Factors for Multisystem Inflammatory Syndrome in Children: A Case-control Investigation
The Pediatric Infectious Disease Journal
June 1, 2023
Extracorporeal Membrane Oxygenation Characteristics and Outcomes in Children and Adolescents With COVID-19 or Multisystem Inflammatory Syndrome Admitted to U.S. ICUs
Pediatric Critical Care Medicine
May 1, 2023
Circulating Spike Protein Detected in Post-COVID-19 mRNA Vaccine Myocarditis
Circulation
March 14, 2023
Variation in Early Anakinra Use and Short-Term Outcomes in Multisystem Inflammatory Syndrome in Children
Arthritis and Rheumatology
March 12, 2023
Community-Onset Bacterial Coinfection in Children Critically Ill With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Open Forum Infectious Diseases
March 6, 2023
Clinical Course Associated with Aseptic Meningitis Induced by Intravenous Immunoglobulin for the Treatment of Multisystem Inflammatory Syndrome in Children
Journal of Pediatrics
March 3, 2023
Factors Associated With COVID-19 Non-vaccination in Adolescents Hospitalized Without COVID-19
Journal of the Pediatric Infectious Diseases Society
February 9, 2023
The Notch1/CD22 signaling axis disrupts Treg function in SARS-CoV-2-associated multisystem inflammatory syndrome in children
The Journal of Clinical Investigation
January 3, 2023
Changes in Distribution of Severe Neurologic Involvement in US Pediatric Inpatients With COVID-19 or Multisystem Inflammatory Syndrome in Children in 2021 vs 2020
JAMA Neurology
January 1, 2023
NFKB2 haploinsufficiency identified via screening for IFN-α2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2-related complications
Journal of Allergy and Clinical Immunology
December 9, 2022
Postdischarge Glucocorticoid Use and Clinical Outcomes of Multisystem Inflammatory Syndrome in Children
JAMA Network Open
November 1, 2022
Investigating Health Disparities Associated With Multisystem Inflammatory Syndrome in Children After SARS-CoV-2 Infection
The Pediatric Infectious Disease Journal
November 1, 2022
Tachyarrhythmias During Hospitalization for COVID-19 or Multisystem Inflammatory Syndrome in Children and Adolescents
Journal of the American Heart Association
October 18, 2022
BNT162b2 mRNA Vaccination Against COVID-19 is Associated with Decreased Likelihood of Multisystem Inflammatory Syndrome in U.S. Children Ages 5-18 Years
Clinical Infectious Diseases
August 4, 2022
Health Impairments in Children and Adolescents After Hospitalization for Acute COVID-19 or MIS-C
Pediatrics
June 29, 2022
Treatment of Multisystem Inflammatory Syndrome in Children: Understanding Differences in Results of Comparative Effectiveness Studies
ACR Open
June 27, 2022
Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants
New England Journal of Medicine
June 22, 2022
Preliminary data reported in MMWR:
Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19–Associated Hospitalization in Infants Aged <6 Months — 17 States, July 2021–January 2022
Morbidity and Mortality Weekly Report
February 15, 2022
Life-Threatening Complications of Influenza versus COVID-19 in U.S. Children
Clinical Infectious Diseases
June 19, 2022
Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C
Nature Communications
May 27, 2022
BNT162b2 Protection against the Omicron Variant in Children and Adolescents
New England Journal of Medicine
March 30, 2022
Measurement of SARS-CoV-2 antigens in plasma of pediatric patients with acute COVID-19 or MIS-C using an ultrasensitive and quantitative immunoassay
Clinical Infectious Diseases
February 25, 2022
Systemic and Lower Respiratory Tract Immunity to SARS-CoV-2 Omicron and Variants in Pediatric Severe COVID-19 and MIS-C
Vaccines
February 10, 2022
Immunology of SARS-CoV-2 infection in children
Nature Immunology
February 1, 2022
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021
Morbidity and Mortality Weekly Report
January 14, 2022
Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents
New England Journal of Medicine
January 12, 2022
Preliminary data reported in MMWR:
Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12-18 Years - United States, June-September 2021
Morbidity and Mortality Weekly Report
October 22, 2021
A Description of COVID-19-Directed Therapy in Children Admitted to US Intensive Care Units 2020
Journal of the Pediatric Infectious Disease Society
January 12, 2022
Frequency, Characteristics and Complications of COVID-19 in Hospitalized Infants
Pediatric Infectious Disease Journal
December 21, 2021
Data-driven clustering identifies features distinguishing multisystem inflammatory syndrome from acute COVID-19 in children and adolescents
EClinicalMedicine
August 31, 2021
Multisystem Inflammatory Syndrome in Children — Initial Therapy and Outcomes
New England Journal of Medicine
June 16, 2021
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome
JAMA Neurology
March 5, 2021
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19
Journal of the American Medical Association
February 24, 2021
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
New England Journal of Medicine
June 29, 2020